New antibody treatment tested for serious liver virus
NCT ID NCT05861674
Summary
This study tested an experimental antibody treatment called HH-003 in adults with chronic hepatitis delta virus infection, a serious liver disease. The goal was to see if the treatment could safely reduce the amount of virus in the blood and improve liver health. It was a mid-stage trial involving 101 participants at multiple medical centers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS DELTA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Ditan Hospital Captial Medical University
Beijing, Beijing Municipality, 100015, China
Conditions
Explore the condition pages connected to this study.